These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 38302729)

  • 1. Role of MARK2 in the nervous system and cancer.
    Lei Y; Zhang R; Cai F
    Cancer Gene Ther; 2024 Apr; 31(4):497-506. PubMed ID: 38302729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409.
    Deng SS; Wu LY; Wang YC; Cao PR; Xu L; Li QR; Liu M; Zhang L; Jiang YJ; Yang XY; Sun SN; Tan MJ; Qian M; Zang Y; Feng L; Li J
    J Biol Chem; 2015 Jan; 290(5):3149-60. PubMed ID: 25512381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
    Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
    Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
    Heras-Sandoval D; Pérez-Rojas JM; Hernández-Damián J; Pedraza-Chaverri J
    Cell Signal; 2014 Dec; 26(12):2694-701. PubMed ID: 25173700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
    Anwar S; Shahwan M; Hasan GM; Islam A; Hassan MI
    Cell Signal; 2022 Nov; 99():110434. PubMed ID: 35961526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
    Shorning BY; Dass MS; Smalley MJ; Pearson HB
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.
    Yu L; Wei J; Liu P
    Semin Cancer Biol; 2022 Oct; 85():69-94. PubMed ID: 34175443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
    Mondal D; Mathur A; Chandra PK
    Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and importance of the PI3K/Akt/mTOR signaling pathway in hematologic malignancies.
    Kawauchi K; Ogasawara T; Yasuyama M; Otsuka K; Yamada O
    Anticancer Agents Med Chem; 2009 Nov; 9(9):1024-38. PubMed ID: 19663778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.
    Ponnusamy L; Natarajan SR; Manoharan R
    J Cell Biochem; 2022 Apr; 123(4):759-771. PubMed ID: 35048405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.
    Zhang C; Yang N; Yang CH; Ding HS; Luo C; Zhang Y; Wu MJ; Zhang XW; Shen X; Jiang HL; Meng LH; Ding J
    PLoS One; 2009; 4(3):e4881. PubMed ID: 19293927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer.
    Zhu K; Wu Y; He P; Fan Y; Zhong X; Zheng H; Luo T
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
    Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
    J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.
    Ediriweera MK; Tennekoon KH; Samarakoon SR
    Semin Cancer Biol; 2019 Dec; 59():147-160. PubMed ID: 31128298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer.
    Wylaź M; Kaczmarska A; Pajor D; Hryniewicki M; Gil D; Dulińska-Litewka J
    Biomed Pharmacother; 2023 Dec; 168():115676. PubMed ID: 37832401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astaxanthin Inhibits Matrix Metalloproteinase Expression by Suppressing PI3K/AKT/mTOR Activation in
    Lee J; Lim JW; Kim H
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.